Induction Toripalimab And Chemotherapy For Organ Preservation In Locally Advanced Laryngeal And Hypopharyngeal Cancer: A Single-Arm Phase 2 Clinical Trial

CONCLUSIONS: Induction toripalimab combined with chemotherapy provided encouraging activity, promising larynx preservation rate and acceptable toxicity in this cohort of extensively locally advanced laryngeal and hypopharyngeal cancer.PMID:37955629 | DOI:10.1158/1078-0432.CCR-23-2398

Source: Clinical Cancer Research - November 13, 2023 Category: Cancer & Oncology Authors: Xiaomin Ou Ruiping Zhai Wenjun Wei Jiaying Chen Dan Ou Tian Liao Tingting Xu Yongxue Zhu Yulong Wang Shenglin Huang Rongliang Shi Bin Wu Tongzhen Chen Yuan Li Zhongyi Yang Changming Zhou Yuan Liu Ziting Jiang Min Zeng Xin Liu Dongmei Ji Hongmei Ying Zhen Source Type: research